tiprankstipranks
Centessa Pharmaceuticals (CNTA)
NASDAQ:CNTA
US Market
CNTA
Centessa Pharmaceuticals
RESEARCH TOOLSreports
Want to see CNTA full AI Analyst Report?

Centessa Pharmaceuticals (CNTA) Income Statement

233 Followers

Centessa Pharmaceuticals Income Statement

Last quarter (Q4 2025), Centessa Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Centessa Pharmaceuticals's net income was $-66.16M. See Centessa Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 15.00M$ 0.00$ 6.85M$ 0.00$ 0.00
Gross Profit
$ 15.00M$ 0.00$ 6.85M$ 0.00$ 0.00
Operating Expenses
$ 222.69M$ 201.06M$ 178.14M$ 212.26M$ 374.87M
Depreciation and Amortization
$ 0.00$ 942.00K$ 810.00K$ 131.00K$ 34.00K
EBITDA
$ -207.69M$ -221.88M$ -165.43M$ -209.55M$ -139.30M
Operating Income
$ -207.69M$ -201.06M$ -171.28M$ -212.26M$ -374.87M
Other Income/Expenses
$ 11.98M$ -31.86M$ -4.86M$ -4.69M$ -6.92M
Pretax Income
$ -195.71M$ -232.91M$ -176.14M$ -216.95M$ -381.79M
Net Income
$ -197.53M$ -235.76M$ -151.09M$ -216.21M$ -381.90M
Per Share Metrics
Basic EPS
$ -1.46$ -2.06$ -1.57$ -2.31$ -4.24
Diluted EPS
$ -1.46$ -2.06$ -1.57$ -2.31$ -4.24
Weighted Average Shares Outstanding
 135.72M 114.47M 96.18M 93.40M 89.99M
Weighted Average Shares Outstanding (Diluted)
 135.72M 114.47M 96.18M 93.40M 89.99M
Currency in USD

Centessa Pharmaceuticals Earnings and Revenue History